CDC6 and pancreatic neoplasm: Furthermore, the expression of CDC6 is upregulated in multiple tumor types [27, 28]; CDC6 serves as a prognostic biomarker of breast carcinoma [29], colorectal cancer [30], pancreatic cancer [31], and other cancers.